Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Change in Receivables (2019 - 2025)

Historic Change in Receivables for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to -$1.8 million.

  • Outset Medical's Change in Receivables fell 19208.33% to -$1.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.8 million, marking a year-over-year decrease of 17531.92%. This contributed to the annual value of -$3.8 million for FY2025, which is 17531.92% down from last year.
  • Latest data reveals that Outset Medical reported Change in Receivables of -$1.8 million as of Q4 2025, which was down 19208.33% from -$2.9 million recorded in Q3 2025.
  • Outset Medical's Change in Receivables' 5-year high stood at $6.3 million during Q4 2021, with a 5-year trough of -$2.9 million in Q3 2025.
  • Its 5-year average for Change in Receivables is $1.4 million, with a median of $1.4 million in 2022.
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 151073.17% in 2021, then plummeted by 218633.09% in 2025.
  • Over the past 5 years, Outset Medical's Change in Receivables (Quarter) stood at $6.3 million in 2021, then fell by 11.34% to $5.6 million in 2022, then plummeted by 144.23% to -$2.5 million in 2023, then soared by 177.73% to $1.9 million in 2024, then plummeted by 192.08% to -$1.8 million in 2025.
  • Its Change in Receivables was -$1.8 million in Q4 2025, compared to -$2.9 million in Q3 2025 and -$574000.0 in Q2 2025.